{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:41:49Z","timestamp":1785404509082,"version":"3.56.0"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cytopathology"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The benign call rate (BCR) is the percentage of cytomorphologically indeterminate cases with subsequent benign or negative molecular results. For rule\u2010out tests, the BCR is an important parameter because these molecular \u201cnegative\u201d cases may be managed similarly to those with a benign cytology diagnosis. Although earlier versions of ThyroSeq molecular tests were less effective in excluding malignancy, the extensively expanded v3 version with a high negative predictive value is considered to represent a rule\u2010out test. In the current study, the authors evaluated the BCR and the overall molecular result distribution of ThyroSeq v3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All indeterminate thyroid fine\u2010needle aspiration cases (except those deemed suspicious for malignancy) with available ThyroSeq v3 results from November 2017 to June 2018 were retrieved from the cytopathology files. Because the ThyroSeq v3 genomic classifier was designed for thyroid follicular\u2010derived lesions, cases in which parathyroid and medullary carcinoma molecular markers were detected and those that were inadequate or limited for molecular testing were excluded from the study. For the remaining cases, the indeterminate diagnoses were correlated with molecular and histologic results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 224 indeterminate cases (except those deemed suspicious for malignancy), the overall ThyroSeq v3 molecular test BCR was 74.1% (166 of 224 cases). The category of atypia of undetermined significance\/follicular lesion of undetermined significance (AUS\/FLUS) had higher BCRs compared with the other indeterminate diagnostic categories. <jats:italic>RAS<\/jats:italic> mutations were the most common positive results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The high BCR demonstrates that ThyroSeq v3 is potentially effective in sparing the large majority of indeterminate cases with \u201cnegative\u201d results from surgery while offering risk assessment for the positive cases and guiding clinical management.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncy.22088","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T10:28:10Z","timestamp":1545128890000},"page":"161-168","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Benign call rate and molecular test result distribution of ThyroSeq v3"],"prefix":"10.1002","volume":"127","author":[{"given":"N. Paul","family":"Ohori","sequence":"first","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Landau","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally E.","family":"Carty","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwah","family":"Yip","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane O.","family":"LeBeau","sequence":"additional","affiliation":[{"name":"Division of Endocrinology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Manroa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja R.","family":"Seethala","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Schoedel","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina N.","family":"Nikiforova","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri E.","family":"Nikiforov","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center\u2010Presbyterian Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-60570-8"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0174-RA"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0100-RA"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.1153"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4486-3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203208"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2482"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP13330.OR"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3584"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21455"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0049"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21749"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.4274\/2017.26.suppl.05"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21827"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21879"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1469"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2292"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29038"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0305"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31245"},{"key":"e_1_2_8_23_1","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study","author":"Steward DL","journal-title":"JAMA Oncol"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0386"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23915"},{"key":"e_1_2_8_26_1","unstructured":"ThyroSeq.ThyroSeq Thyroid Genomic Classifier.https:\/\/thyroseq.com\/home. Accessed on October 8. 2018."},{"key":"e_1_2_8_27_1","unstructured":"Network National Comprehensive Cancer.About the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).https:\/\/www.nccn.org\/professionals\/. Accessed on October 9 2018."}],"container-title":["Cancer Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncy.22088","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncy.22088","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncy.22088","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncy.22088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T21:22:14Z","timestamp":1760304134000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncy.22088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1002\/cncy.22088"],"URL":"https:\/\/doi.org\/10.1002\/cncy.22088","archive":["Portico"],"relation":{},"ISSN":["1934-662X","1934-6638"],"issn-type":[{"value":"1934-662X","type":"print"},{"value":"1934-6638","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]},"assertion":[{"value":"2018-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}